Latest Vertex Pharmaceuticals Stories
Prime Therapeutics study finds combination treatment targeting gene mutations could add approximately $150 million per year in new costs ST.
DALLAS, March 12, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Cystic Fibrosis - Pipeline Review, H1 2015" therapeutic market research report provides an overview of
Global Cystic Fibrosis Market 2015-2019 is a new industry research report which profiles key players like Actavis, Novartis, Gilead Sciences, Vertex Pharmaceuticals and F Hoffmann-La Roche.
Funds will be used to expand cystic fibrosis research, care and patient programs BETHESDA, Md., Nov.
Largest pharmaceutical royalty purchase ever completed NEW YORK, Nov.
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, October 27, 2014 /PRNewswire/ -- Today, Analysts Review released its research
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, August 29, 2014 /PRNewswire/ -- Today, Analysts Review released its research
- Growing in low tufty patches.